[ Price : $8.95]
Federal Register Notice: FDA publishes a notice that an applicant for a proposed biosimilar product notified the agency that a pat...[ Price : $8.95]
Federal Register Notice: FDA seeks public comments on a proposed collection of certain information to support social and behaviora...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance entitled S9 Nonclinical Evaluation for Anticancer PharmaceuticalsQuestions and...[ Price : $8.95]
Federal Register Notice: FDA announces a public meeting entitled Health Canada and FDA Joint Public Consultation on International ...[ Price : $8.95]
FDA approves Bayers Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a progestin-containing intrauterine system for...[ Price : $8.95]
Federal Register Notice. FDA announces a public meeting to discuss proposed recommendations for reauthorizing the Biosimilar User ...[ Price : $8.95]
Federal Register Notice: FDA annouces a public meeting entitled Progress Toward Implementing the Product Identification Requiremen...[ Price : $8.95]
In an unprecedented move, FDA commissioner Robert Califf upholds CDER director Janet Woodocks unusual role in reviewing and approv...